Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Blinding01:11

Blinding

2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Financial toxicity among breast cancer survivors receiving care during the pandemic.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Colorectal Cancer Screening Materials for Tribal Communities in the Great Plains and Washington State: Application of Boot Camp Translation.

The Permanente journal·2026
Same author

Serious Illness and Health Care Threats to Personal Legacy Goals.

The Permanente journal·2026
Same author

Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Blood tests for colorectal cancer-Hype ahead of evidence?

CA: a cancer journal for clinicians·2026
Same author

Disparities in Timeliness of Cancer Diagnosis Across a Multi-Site Academic Health System.

Research square·2026

Related Experiment Video

Updated: Jun 10, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K

A roadmap for improving representation in clinical trials.

Amanda F Petrik1, Nora B Henrikson2, Gloria D Coronado1,3

  • 1Kaiser Permanente Center for Health Research, 3800 N. Interstate Ave, Portland, OR, 97227, United States.

Contemporary Clinical Trials Communications
|October 11, 2024
PubMed
Summary
This summary is machine-generated.

Recruiting diverse patients, including underrepresented minorities and low-income individuals, for clinical trials is achievable. The CAFÉ study demonstrated higher consent rates among diverse and Spanish-speaking participants, leading to more generalizable health science findings.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.6K

Related Experiment Videos

Last Updated: Jun 10, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.6K

Area of Science:

  • Health Sciences
  • Clinical Trial Recruitment
  • Health Equity

Background:

  • Clinical trials face challenges in recruiting diverse participants, particularly underrepresented minorities and low-income patients.
  • Diverse participant enrollment is crucial for enhancing the generalizability of health science findings.
  • The Cancer Financial Experience (CAFÉ) project aimed to address financial distress in cancer patients while prioritizing diverse recruitment.

Purpose of the Study:

  • To describe methods for increasing the recruitment of diverse participants in clinical trials.
  • To highlight the importance of diverse enrollment for robust and applicable research outcomes.

Main Methods:

  • The CAFÉ study intentionally recruited a diverse patient population.
  • Consent rates were compared between diverse and non-diverse participants, as well as between Spanish-speaking and non-Spanish-speaking patients.

Main Results:

  • Diverse participants showed slightly higher consent rates (21.3%) compared to non-diverse participants (20.1%).
  • Spanish-speaking patients had significantly higher consent rates (36.4%) than non-Spanish speakers (20.2%).

Conclusions:

  • Achieving diverse participation in clinical trials is feasible.
  • Targeted recruitment strategies can improve the inclusion of underrepresented groups.
  • Diverse participant data leads to more meaningful and broadly applicable research findings.